“Efficacy of Apremilast in Patients with Moderate-to-Severe Genital Psoriasis: Body Surface Area Subgroup Results from the Phase 3 DISCREET Trial” (2023) SKIN The Journal of Cutaneous Medicine, 7(6), p. s255. doi:10.25251/skin.7.supp.255.